nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR1D—meninx—intracranial aneurysm	0.0889	0.0974	CbGeAlD
Loxapine—HTR1B—dura mater—intracranial aneurysm	0.0845	0.0926	CbGeAlD
Loxapine—HTR1D—dura mater—intracranial aneurysm	0.0818	0.0897	CbGeAlD
Loxapine—HTR2C—choroid plexus—intracranial aneurysm	0.0689	0.0755	CbGeAlD
Loxapine—HTR1B—trigeminal nerve—intracranial aneurysm	0.0363	0.0398	CbGeAlD
Loxapine—HTR1D—trigeminal nerve—intracranial aneurysm	0.0352	0.0386	CbGeAlD
Loxapine—HTR2A—choroid plexus—intracranial aneurysm	0.0345	0.0379	CbGeAlD
Loxapine—HTR3A—cranial nerve—intracranial aneurysm	0.0308	0.0338	CbGeAlD
Loxapine—HTR1B—cranial nerve—intracranial aneurysm	0.0259	0.0284	CbGeAlD
Loxapine—HTR7—vein—intracranial aneurysm	0.0253	0.0278	CbGeAlD
Loxapine—HTR1D—cranial nerve—intracranial aneurysm	0.0251	0.0275	CbGeAlD
Loxapine—HTR7—cranial nerve—intracranial aneurysm	0.02	0.0219	CbGeAlD
Loxapine—HTR7—pons—intracranial aneurysm	0.0197	0.0216	CbGeAlD
Loxapine—HTR2A—trigeminal nerve—intracranial aneurysm	0.0175	0.0192	CbGeAlD
Loxapine—HTR2A—vein—intracranial aneurysm	0.0158	0.0173	CbGeAlD
Loxapine—HTR1B—artery—intracranial aneurysm	0.0134	0.0147	CbGeAlD
Loxapine—HTR1D—artery—intracranial aneurysm	0.0129	0.0142	CbGeAlD
Loxapine—HTR2A—cranial nerve—intracranial aneurysm	0.0124	0.0136	CbGeAlD
Loxapine—HTR2A—pons—intracranial aneurysm	0.0123	0.0135	CbGeAlD
Loxapine—HTR1E—brainstem—intracranial aneurysm	0.012	0.0132	CbGeAlD
Loxapine—HTR5A—brain—intracranial aneurysm	0.0113	0.0124	CbGeAlD
Loxapine—HTR7—artery—intracranial aneurysm	0.0103	0.0113	CbGeAlD
Loxapine—DRD1—brainstem—intracranial aneurysm	0.00703	0.00771	CbGeAlD
Loxapine—HTR3A—brainstem—intracranial aneurysm	0.00679	0.00744	CbGeAlD
Loxapine—HTR2A—artery—intracranial aneurysm	0.00643	0.00705	CbGeAlD
Loxapine—HTR1B—brainstem—intracranial aneurysm	0.00569	0.00624	CbGeAlD
Loxapine—SLC6A3—brainstem—intracranial aneurysm	0.00565	0.00619	CbGeAlD
Loxapine—DRD4—brain—intracranial aneurysm	0.00559	0.00613	CbGeAlD
Loxapine—HTR1D—brainstem—intracranial aneurysm	0.00551	0.00604	CbGeAlD
Loxapine—HTR2C—brainstem—intracranial aneurysm	0.00546	0.00599	CbGeAlD
Loxapine—SLC6A4—brainstem—intracranial aneurysm	0.00517	0.00567	CbGeAlD
Loxapine—HTR1E—brain—intracranial aneurysm	0.00482	0.00529	CbGeAlD
Loxapine—HTR1A—brainstem—intracranial aneurysm	0.00459	0.00504	CbGeAlD
Loxapine—SLC6A2—brainstem—intracranial aneurysm	0.00456	0.005	CbGeAlD
Loxapine—DRD1—midbrain—intracranial aneurysm	0.00448	0.00491	CbGeAlD
Loxapine—HTR7—brainstem—intracranial aneurysm	0.00439	0.00481	CbGeAlD
Loxapine—ADRA1A—brainstem—intracranial aneurysm	0.00424	0.00464	CbGeAlD
Loxapine—CHRM4—brain—intracranial aneurysm	0.00423	0.00464	CbGeAlD
Loxapine—DRD2—brainstem—intracranial aneurysm	0.00415	0.00455	CbGeAlD
Loxapine—DRD3—brain—intracranial aneurysm	0.00393	0.00431	CbGeAlD
Loxapine—HTR2C—medulla oblongata—intracranial aneurysm	0.00381	0.00417	CbGeAlD
Loxapine—HTR6—brain—intracranial aneurysm	0.00378	0.00415	CbGeAlD
Loxapine—DRD5—brain—intracranial aneurysm	0.00368	0.00404	CbGeAlD
Loxapine—HTR1B—midbrain—intracranial aneurysm	0.00363	0.00398	CbGeAlD
Loxapine—SLC6A3—midbrain—intracranial aneurysm	0.0036	0.00395	CbGeAlD
Loxapine—HTR1D—midbrain—intracranial aneurysm	0.00351	0.00385	CbGeAlD
Loxapine—HTR2C—midbrain—intracranial aneurysm	0.00348	0.00381	CbGeAlD
Loxapine—HRH2—brain—intracranial aneurysm	0.00346	0.00379	CbGeAlD
Loxapine—CHRM5—brain—intracranial aneurysm	0.0033	0.00362	CbGeAlD
Loxapine—SLC6A4—midbrain—intracranial aneurysm	0.0033	0.00362	CbGeAlD
Loxapine—SLC6A2—medulla oblongata—intracranial aneurysm	0.00318	0.00348	CbGeAlD
Loxapine—HTR7—medulla oblongata—intracranial aneurysm	0.00306	0.00336	CbGeAlD
Loxapine—ADRA1B—brain—intracranial aneurysm	0.00302	0.00331	CbGeAlD
Loxapine—HTR1A—midbrain—intracranial aneurysm	0.00293	0.00321	CbGeAlD
Loxapine—ADRA2C—medulla oblongata—intracranial aneurysm	0.00281	0.00309	CbGeAlD
Loxapine—DRD1—brain—intracranial aneurysm	0.00281	0.00309	CbGeAlD
Loxapine—HTR7—midbrain—intracranial aneurysm	0.0028	0.00307	CbGeAlD
Loxapine—SLC6A3—cerebellum—intracranial aneurysm	0.00278	0.00305	CbGeAlD
Loxapine—HTR2A—brainstem—intracranial aneurysm	0.00274	0.003	CbGeAlD
Loxapine—HTR3A—brain—intracranial aneurysm	0.00272	0.00298	CbGeAlD
Loxapine—DRD2—midbrain—intracranial aneurysm	0.00265	0.0029	CbGeAlD
Loxapine—ADRA2C—midbrain—intracranial aneurysm	0.00257	0.00282	CbGeAlD
Loxapine—HTR1B—brain—intracranial aneurysm	0.00228	0.0025	CbGeAlD
Loxapine—CHRM2—brain—intracranial aneurysm	0.00227	0.00249	CbGeAlD
Loxapine—HTR1A—cerebellum—intracranial aneurysm	0.00227	0.00248	CbGeAlD
Loxapine—SLC6A3—brain—intracranial aneurysm	0.00226	0.00248	CbGeAlD
Loxapine—ADRA2A—medulla oblongata—intracranial aneurysm	0.00225	0.00246	CbGeAlD
Loxapine—HTR1D—brain—intracranial aneurysm	0.00221	0.00242	CbGeAlD
Loxapine—HTR2C—brain—intracranial aneurysm	0.00219	0.0024	CbGeAlD
Loxapine—HTR7—cerebellum—intracranial aneurysm	0.00216	0.00237	CbGeAlD
Loxapine—ADRB1—brain—intracranial aneurysm	0.00214	0.00235	CbGeAlD
Loxapine—ADRA1A—cerebellum—intracranial aneurysm	0.00209	0.00229	CbGeAlD
Loxapine—SLC6A4—brain—intracranial aneurysm	0.00207	0.00227	CbGeAlD
Loxapine—CHRM1—brain—intracranial aneurysm	0.00206	0.00226	CbGeAlD
Loxapine—ADRA2A—midbrain—intracranial aneurysm	0.00205	0.00225	CbGeAlD
Loxapine—DRD2—cerebellum—intracranial aneurysm	0.00205	0.00224	CbGeAlD
Loxapine—ADRA2C—cerebellum—intracranial aneurysm	0.00199	0.00218	CbGeAlD
Loxapine—HTR2A—medulla oblongata—intracranial aneurysm	0.00191	0.00209	CbGeAlD
Loxapine—CHRM3—brain—intracranial aneurysm	0.00185	0.00203	CbGeAlD
Loxapine—HTR1A—brain—intracranial aneurysm	0.00184	0.00202	CbGeAlD
Loxapine—SLC6A2—brain—intracranial aneurysm	0.00182	0.002	CbGeAlD
Loxapine—HTR7—brain—intracranial aneurysm	0.00176	0.00193	CbGeAlD
Loxapine—HTR2A—midbrain—intracranial aneurysm	0.00174	0.00191	CbGeAlD
Loxapine—ADRA1A—brain—intracranial aneurysm	0.0017	0.00186	CbGeAlD
Loxapine—DRD2—brain—intracranial aneurysm	0.00166	0.00182	CbGeAlD
Loxapine—ADRA2C—brain—intracranial aneurysm	0.00162	0.00177	CbGeAlD
Loxapine—ADRA2A—cerebellum—intracranial aneurysm	0.00159	0.00174	CbGeAlD
Loxapine—HTR2A—cerebellum—intracranial aneurysm	0.00135	0.00148	CbGeAlD
Loxapine—HRH1—brain—intracranial aneurysm	0.00131	0.00144	CbGeAlD
Loxapine—ADRA2A—brain—intracranial aneurysm	0.00129	0.00141	CbGeAlD
Loxapine—HTR2A—brain—intracranial aneurysm	0.0011	0.0012	CbGeAlD
Loxapine—HTR6—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000142	0.00161	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000142	0.00161	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000141	0.0016	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—EDNRA—intracranial aneurysm	0.000141	0.0016	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000141	0.0016	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—TIMP1—intracranial aneurysm	0.00014	0.00159	CbGpPWpGaD
Loxapine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000139	0.00157	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000138	0.00157	CbGpPWpGaD
Loxapine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000137	0.00156	CbGpPWpGaD
Loxapine—HTR6—GPCR ligand binding—CCL2—intracranial aneurysm	0.000137	0.00155	CbGpPWpGaD
Loxapine—HTR7—GPCR ligand binding—CCL2—intracranial aneurysm	0.000136	0.00155	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000136	0.00154	CbGpPWpGaD
Loxapine—HTR1D—GPCR ligand binding—CCL2—intracranial aneurysm	0.000135	0.00154	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000135	0.00153	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000134	0.00152	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—ASAH1—intracranial aneurysm	0.000134	0.00152	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000133	0.00151	CbGpPWpGaD
Loxapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000133	0.00151	CbGpPWpGaD
Loxapine—HTR1B—GPCR ligand binding—CCL2—intracranial aneurysm	0.000133	0.00151	CbGpPWpGaD
Loxapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000132	0.0015	CbGpPWpGaD
Loxapine—DRD4—GPCR ligand binding—CCL2—intracranial aneurysm	0.000131	0.00148	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—NCF1—intracranial aneurysm	0.00013	0.00148	CbGpPWpGaD
Loxapine—CHRM4—GPCR ligand binding—CCL2—intracranial aneurysm	0.000129	0.00146	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000128	0.00146	CbGpPWpGaD
Loxapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000128	0.00146	CbGpPWpGaD
Loxapine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000126	0.00143	CbGpPWpGaD
Loxapine—CHRM5—GPCR ligand binding—CCL2—intracranial aneurysm	0.000123	0.0014	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—ASAH1—intracranial aneurysm	0.000123	0.0014	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—EDNRA—intracranial aneurysm	0.000123	0.0014	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000122	0.00139	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000121	0.00137	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000121	0.00137	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00012	0.00136	CbGpPWpGaD
Loxapine—HRH4—Signaling by GPCR—CCL2—intracranial aneurysm	0.000118	0.00134	CbGpPWpGaD
Loxapine—DRD1—GPCR ligand binding—CCL2—intracranial aneurysm	0.000118	0.00133	CbGpPWpGaD
Loxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000117	0.00132	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—NCF1—intracranial aneurysm	0.000116	0.00132	CbGpPWpGaD
Loxapine—DRD3—GPCR ligand binding—CCL2—intracranial aneurysm	0.000116	0.00132	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000116	0.00132	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000115	0.00131	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—NCF1—intracranial aneurysm	0.000115	0.00131	CbGpPWpGaD
Loxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000115	0.0013	CbGpPWpGaD
Loxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000114	0.0013	CbGpPWpGaD
Loxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000114	0.00129	CbGpPWpGaD
Loxapine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000114	0.00129	CbGpPWpGaD
Loxapine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000113	0.00128	CbGpPWpGaD
Loxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000112	0.00127	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—CCL2—intracranial aneurysm	0.000112	0.00127	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000112	0.00127	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00011	0.00125	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00011	0.00125	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—EDNRA—intracranial aneurysm	0.00011	0.00124	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000109	0.00124	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—EDNRA—intracranial aneurysm	0.000109	0.00123	CbGpPWpGaD
Loxapine—ADRB1—GPCR ligand binding—CCL2—intracranial aneurysm	0.000106	0.0012	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000105	0.00119	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000105	0.00119	CbGpPWpGaD
Loxapine—ADRA2B—GPCR ligand binding—CCL2—intracranial aneurysm	0.000105	0.00119	CbGpPWpGaD
Loxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000104	0.00118	CbGpPWpGaD
Loxapine—HTR1E—Signaling by GPCR—CCL2—intracranial aneurysm	0.000103	0.00116	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000102	0.00116	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000102	0.00115	CbGpPWpGaD
Loxapine—HTR1A—GPCR ligand binding—CCL2—intracranial aneurysm	0.000101	0.00115	CbGpPWpGaD
Loxapine—HTR2C—GPCR ligand binding—CCL2—intracranial aneurysm	0.000101	0.00114	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—EDNRA—intracranial aneurysm	0.0001	0.00114	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.0001	0.00114	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—NOS3—intracranial aneurysm	0.0001	0.00113	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—EDNRA—intracranial aneurysm	9.99e-05	0.00113	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—EDNRA—intracranial aneurysm	9.96e-05	0.00113	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—EDNRA—intracranial aneurysm	9.93e-05	0.00113	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—EDNRA—intracranial aneurysm	9.83e-05	0.00112	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—EDNRA—intracranial aneurysm	9.8e-05	0.00111	CbGpPWpGaD
Loxapine—ADRA2C—GPCR ligand binding—CCL2—intracranial aneurysm	9.78e-05	0.00111	CbGpPWpGaD
Loxapine—ADRA1B—GPCR ligand binding—CCL2—intracranial aneurysm	9.62e-05	0.00109	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—EDNRA—intracranial aneurysm	9.24e-05	0.00105	CbGpPWpGaD
Loxapine—HRH2—Signaling by GPCR—CCL2—intracranial aneurysm	9.13e-05	0.00104	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—EDNRA—intracranial aneurysm	9.11e-05	0.00103	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—EDNRA—intracranial aneurysm	9.09e-05	0.00103	CbGpPWpGaD
Loxapine—DRD5—Signaling by GPCR—CCL2—intracranial aneurysm	9.08e-05	0.00103	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—EDNRA—intracranial aneurysm	9.07e-05	0.00103	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—EDNRA—intracranial aneurysm	9.04e-05	0.00103	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—EDNRA—intracranial aneurysm	9.01e-05	0.00102	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—EDNRA—intracranial aneurysm	8.93e-05	0.00101	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—EDNRA—intracranial aneurysm	8.9e-05	0.00101	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—NCF1—intracranial aneurysm	8.89e-05	0.00101	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—NCF1—intracranial aneurysm	8.88e-05	0.00101	CbGpPWpGaD
Loxapine—DRD2—GPCR ligand binding—CCL2—intracranial aneurysm	8.87e-05	0.00101	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—NCF1—intracranial aneurysm	8.83e-05	0.001	CbGpPWpGaD
Loxapine—HTR2A—GPCR ligand binding—CCL2—intracranial aneurysm	8.73e-05	0.000991	CbGpPWpGaD
Loxapine—HRH1—GPCR ligand binding—CCL2—intracranial aneurysm	8.71e-05	0.000989	CbGpPWpGaD
Loxapine—CHRM1—GPCR ligand binding—CCL2—intracranial aneurysm	8.68e-05	0.000985	CbGpPWpGaD
Loxapine—CHRM3—GPCR ligand binding—CCL2—intracranial aneurysm	8.66e-05	0.000982	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—NCF1—intracranial aneurysm	8.64e-05	0.000981	CbGpPWpGaD
Loxapine—CHRM2—GPCR ligand binding—CCL2—intracranial aneurysm	8.57e-05	0.000973	CbGpPWpGaD
Loxapine—ADRA1A—GPCR ligand binding—CCL2—intracranial aneurysm	8.55e-05	0.00097	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—NCF1—intracranial aneurysm	8.5e-05	0.000965	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—EDNRA—intracranial aneurysm	8.4e-05	0.000953	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—EDNRA—intracranial aneurysm	8.39e-05	0.000952	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—NCF1—intracranial aneurysm	8.39e-05	0.000952	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—NOS3—intracranial aneurysm	8.34e-05	0.000947	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—EDNRA—intracranial aneurysm	8.33e-05	0.000946	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—EDNRA—intracranial aneurysm	8.27e-05	0.000939	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—EDNRA—intracranial aneurysm	8.16e-05	0.000926	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—NCF1—intracranial aneurysm	8.03e-05	0.000912	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—EDNRA—intracranial aneurysm	8.03e-05	0.000911	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—MMP9—intracranial aneurysm	8.02e-05	0.00091	CbGpPWpGaD
Loxapine—ADRA2A—GPCR ligand binding—CCL2—intracranial aneurysm	7.94e-05	0.000901	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EDNRA—intracranial aneurysm	7.92e-05	0.000899	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—NOS3—intracranial aneurysm	7.79e-05	0.000884	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NCF1—intracranial aneurysm	7.66e-05	0.000869	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EDNRA—intracranial aneurysm	7.59e-05	0.000861	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NCF1—intracranial aneurysm	7.55e-05	0.000857	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EDNRA—intracranial aneurysm	7.23e-05	0.00082	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EDNRA—intracranial aneurysm	7.13e-05	0.000809	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—CCL2—intracranial aneurysm	7.01e-05	0.000795	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—CCL2—intracranial aneurysm	7e-05	0.000794	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—CCL2—intracranial aneurysm	6.96e-05	0.00079	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—CCL2—intracranial aneurysm	6.95e-05	0.000789	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NCF1—intracranial aneurysm	6.88e-05	0.000781	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NCF1—intracranial aneurysm	6.82e-05	0.000774	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—CCL2—intracranial aneurysm	6.81e-05	0.000773	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—CCL2—intracranial aneurysm	6.7e-05	0.00076	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—CCL2—intracranial aneurysm	6.61e-05	0.00075	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NCF1—intracranial aneurysm	6.58e-05	0.000747	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NCF1—intracranial aneurysm	6.55e-05	0.000743	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EDNRA—intracranial aneurysm	6.5e-05	0.000738	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EDNRA—intracranial aneurysm	6.44e-05	0.000731	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NCF1—intracranial aneurysm	6.37e-05	0.000723	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—NOS3—intracranial aneurysm	6.33e-05	0.000718	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—CCL2—intracranial aneurysm	6.33e-05	0.000718	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NCF1—intracranial aneurysm	6.27e-05	0.000711	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EDNRA—intracranial aneurysm	6.22e-05	0.000705	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—NOS3—intracranial aneurysm	6.2e-05	0.000704	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EDNRA—intracranial aneurysm	6.18e-05	0.000702	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—CCL2—intracranial aneurysm	6.06e-05	0.000688	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—CCL2—intracranial aneurysm	6.03e-05	0.000684	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EDNRA—intracranial aneurysm	6.02e-05	0.000683	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—CCL2—intracranial aneurysm	5.95e-05	0.000675	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EDNRA—intracranial aneurysm	5.92e-05	0.000672	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NCF1—intracranial aneurysm	5.78e-05	0.000656	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NCF1—intracranial aneurysm	5.69e-05	0.000645	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NCF1—intracranial aneurysm	5.67e-05	0.000644	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NCF1—intracranial aneurysm	5.66e-05	0.000642	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NCF1—intracranial aneurysm	5.64e-05	0.00064	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NCF1—intracranial aneurysm	5.58e-05	0.000634	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NCF1—intracranial aneurysm	5.57e-05	0.000632	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EDNRA—intracranial aneurysm	5.46e-05	0.000619	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—CCL2—intracranial aneurysm	5.42e-05	0.000615	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—NOS3—intracranial aneurysm	5.4e-05	0.000613	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—CCL2—intracranial aneurysm	5.4e-05	0.000612	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—CCL2—intracranial aneurysm	5.37e-05	0.00061	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EDNRA—intracranial aneurysm	5.37e-05	0.000609	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—CCL2—intracranial aneurysm	5.36e-05	0.000608	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EDNRA—intracranial aneurysm	5.36e-05	0.000608	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EDNRA—intracranial aneurysm	5.34e-05	0.000606	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EDNRA—intracranial aneurysm	5.33e-05	0.000604	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EDNRA—intracranial aneurysm	5.27e-05	0.000598	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EDNRA—intracranial aneurysm	5.26e-05	0.000597	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—CCL2—intracranial aneurysm	5.19e-05	0.000588	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NCF1—intracranial aneurysm	5.17e-05	0.000587	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—CCL2—intracranial aneurysm	5.16e-05	0.000585	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—CCL2—intracranial aneurysm	5.02e-05	0.000569	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—MMP9—intracranial aneurysm	4.98e-05	0.000565	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—CCL2—intracranial aneurysm	4.94e-05	0.00056	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EDNRA—intracranial aneurysm	4.89e-05	0.000554	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—NOS3—intracranial aneurysm	4.81e-05	0.000546	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—NOS3—intracranial aneurysm	4.78e-05	0.000542	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—CCL2—intracranial aneurysm	4.55e-05	0.000517	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—CCL2—intracranial aneurysm	4.48e-05	0.000508	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—CCL2—intracranial aneurysm	4.47e-05	0.000507	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—CCL2—intracranial aneurysm	4.46e-05	0.000506	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—CCL2—intracranial aneurysm	4.44e-05	0.000504	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—CCL2—intracranial aneurysm	4.4e-05	0.000499	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—CCL2—intracranial aneurysm	4.39e-05	0.000498	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—MMP9—intracranial aneurysm	4.33e-05	0.000492	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—CCL2—intracranial aneurysm	4.14e-05	0.00047	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—CCL2—intracranial aneurysm	4.13e-05	0.000469	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CCL2—intracranial aneurysm	4.11e-05	0.000466	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—CCL2—intracranial aneurysm	4.08e-05	0.000463	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CCL2—intracranial aneurysm	4.02e-05	0.000456	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CCL2—intracranial aneurysm	3.96e-05	0.000449	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CCL2—intracranial aneurysm	3.9e-05	0.000443	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—MMP9—intracranial aneurysm	3.86e-05	0.000438	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—MMP9—intracranial aneurysm	3.83e-05	0.000435	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CCL2—intracranial aneurysm	3.74e-05	0.000424	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—NOS3—intracranial aneurysm	3.69e-05	0.000419	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—NOS3—intracranial aneurysm	3.68e-05	0.000418	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—NOS3—intracranial aneurysm	3.66e-05	0.000415	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—NOS3—intracranial aneurysm	3.58e-05	0.000407	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CCL2—intracranial aneurysm	3.56e-05	0.000404	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—NOS3—intracranial aneurysm	3.53e-05	0.0004	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CCL2—intracranial aneurysm	3.52e-05	0.000399	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—NOS3—intracranial aneurysm	3.48e-05	0.000395	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—NOS3—intracranial aneurysm	3.33e-05	0.000378	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CCL2—intracranial aneurysm	3.2e-05	0.000363	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NOS3—intracranial aneurysm	3.18e-05	0.00036	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CCL2—intracranial aneurysm	3.17e-05	0.00036	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—NOS3—intracranial aneurysm	3.16e-05	0.000359	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NOS3—intracranial aneurysm	3.13e-05	0.000356	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CCL2—intracranial aneurysm	3.06e-05	0.000348	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CCL2—intracranial aneurysm	3.05e-05	0.000346	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CCL2—intracranial aneurysm	2.96e-05	0.000336	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MMP9—intracranial aneurysm	2.96e-05	0.000336	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MMP9—intracranial aneurysm	2.96e-05	0.000335	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MMP9—intracranial aneurysm	2.94e-05	0.000333	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CCL2—intracranial aneurysm	2.92e-05	0.000331	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MMP9—intracranial aneurysm	2.88e-05	0.000326	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NOS3—intracranial aneurysm	2.85e-05	0.000324	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MMP9—intracranial aneurysm	2.83e-05	0.000321	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NOS3—intracranial aneurysm	2.83e-05	0.000321	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—NOS3—intracranial aneurysm	2.8e-05	0.000317	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MMP9—intracranial aneurysm	2.79e-05	0.000317	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NOS3—intracranial aneurysm	2.73e-05	0.00031	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NOS3—intracranial aneurysm	2.72e-05	0.000308	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCL2—intracranial aneurysm	2.69e-05	0.000305	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MMP9—intracranial aneurysm	2.67e-05	0.000303	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCL2—intracranial aneurysm	2.65e-05	0.0003	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOS3—intracranial aneurysm	2.64e-05	0.0003	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCL2—intracranial aneurysm	2.64e-05	0.0003	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCL2—intracranial aneurysm	2.63e-05	0.000299	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCL2—intracranial aneurysm	2.62e-05	0.000298	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOS3—intracranial aneurysm	2.6e-05	0.000295	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCL2—intracranial aneurysm	2.6e-05	0.000295	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCL2—intracranial aneurysm	2.59e-05	0.000294	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—NOS3—intracranial aneurysm	2.57e-05	0.000291	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MMP9—intracranial aneurysm	2.55e-05	0.000289	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MMP9—intracranial aneurysm	2.51e-05	0.000285	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCL2—intracranial aneurysm	2.41e-05	0.000273	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOS3—intracranial aneurysm	2.4e-05	0.000272	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—intracranial aneurysm	2.36e-05	0.000268	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—intracranial aneurysm	2.35e-05	0.000267	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—intracranial aneurysm	2.35e-05	0.000266	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—intracranial aneurysm	2.34e-05	0.000265	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—intracranial aneurysm	2.32e-05	0.000263	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—intracranial aneurysm	2.31e-05	0.000262	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—intracranial aneurysm	2.29e-05	0.00026	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—intracranial aneurysm	2.27e-05	0.000258	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—intracranial aneurysm	2.19e-05	0.000249	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—intracranial aneurysm	2.18e-05	0.000247	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—intracranial aneurysm	2.15e-05	0.000244	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—intracranial aneurysm	2.12e-05	0.000241	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—intracranial aneurysm	2.09e-05	0.000237	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—intracranial aneurysm	1.92e-05	0.000218	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—intracranial aneurysm	1.89e-05	0.000215	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—intracranial aneurysm	1.89e-05	0.000214	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—intracranial aneurysm	1.88e-05	0.000214	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—intracranial aneurysm	1.88e-05	0.000213	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—intracranial aneurysm	1.86e-05	0.000211	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—intracranial aneurysm	1.85e-05	0.00021	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—intracranial aneurysm	1.72e-05	0.000195	CbGpPWpGaD
